Development and in-vitro characterization of l-cysteine loaded alginate beads for oral delivery

Year 2022, Volume: 26 Issue: 1, 210 - 218, 28.06.2025

Kıvılcım Öztürk

Abstract

The purpose of this work is to develop a biodegradable calcium alginate (Ca-alginate) bead formulation to provide controlled release of l-cysteine (Cys) amino acid for oral drug delivery. Ca-alginate bead formulations were prepared successfully and reproducibly using calcium chloride as a cross-linking agent. The beads were then evaluated in terms of morphology, particle size, swellability, thermal behaviors, encapsulation efficiency, and in-vitro drug release at pH 1.2 and pH 7.4. The size of the beads was measured between 2.230.11 and 2.410.12 mm. In terms of thermal analysis, differential scanning calorimetry was utilized to ensure the encapsulation of Cys into bead formulation. Cys encapsulation was determined as 79.49 %1.12. Swelling index of blank beads were found to be in a range of 0.31-0.35 in HCl solution at pH 1.2; 0.98-1.08 in PBS buffer at pH 7.4. Alginate beads exhibited controlled release, followed the Weibull model which is consistent with the swelling pattern. The physico-chemical properties of the developed formulation indicate that the formulation is suitable for oral Cys delivery.

Keywords

Ca-alginate bead , sodium alginate , oral drug delivery , l-cysteine , controlled release

References

• [1] Miyazaki S, Kubo W, Attwood D. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate. J Control Release. 2000; 67(2-3): 275-280. [CrossRef]
• [2] Hu MH, Zheng GS, Zhao DW, Yu WT. Characterization of the structure and diffusion behavior of calcium alginate gel beads. J Appl Polym Sci. 2020; 137(31): 1-9. [CrossRef]
• [3] Jeong C, Kim S, Lee CM, Cho SM, Kim SB. Changes in the Physical Properties of Calcium Alginate Gel Beads under a Wide Range of Gelation Temperature Conditions. Foods. 2020; 9(2): 180. [CrossRef]
• [4] Hecht H, Srebnik S. Structural Characterization of Sodium Alginate and Calcium Alginate. Biomacromolecules. 2016; 17(6): 2160-2167. [CrossRef]
• [5] Gu F, Amsden B, Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Release. 2004; 96(3): 463-472. [CrossRef]
• [6] Daher B, Vucetic M, Pouyssegur J. Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death. Front Oncol. 2020; 10: 723-731. [CrossRef]
• [7] Miura Y, Honda S, Masuda A, Masuda T. Antioxidant activities of cysteine derivatives against lipid oxidation in anhydrous media. Biosci Biotech Bioch. 2014; 78(8): 1452-14555. [CrossRef]
• [8] Yildiz D, Arik M, Cakir Y, Civi Z. Comparison of N-Acetyl-L-Cysteine and L-Cysteine in Respect to Their Transmembrane Fluxes. Biol Membrany. 2009; 26(2): 143-148. [CrossRef]
• [9] Sameem B, Khan F, Niaz K,Chapter 2.6 - l-Cysteine, Editor(s): Seyed Mohammad Nabavi, Ana Sanches Silva, Nonvitamin and Nonmineral Nutritional Supplements, Academic Press, 2019, pp. 53-58.
• [10] K. M. Amino acids and nitrogen compounds. Nutrient Metabolism: Academic Press; 2003. p. 244-268.
• [11] Ozturk-Atar K, Kaplan M, Calis S. Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate. Drug Dev Ind Pharm. 2020; 46(10): 1695-704. [CrossRef]
• [12] Hua SS. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract-Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol. 2020; 11: 524-545 [CrossRef]
• [13] Turell L, Zeida A, Trujillo M. Mechanisms and consequences of protein cysteine oxidation: the role of the initial short-lived intermediates. Essays Biochem. 2020; 64(1): 55-66. [CrossRef]
• [14] Nagy P, Ashby MT. Reactive sulfur species: Kinetics and mechanisms of the oxidation of cysteine by hypohalous acid to give cysteine sulfenic acid. J Am Chem Soc. 2007; 129(45):14082-14091. [CrossRef]
• [15] Wright SK, Viola RE. Evaluation of methods for the quantitation of cysteines in proteins. Anal Biochem. 1998; 265(1): 8-14. [CrossRef]
• [16] Rehman S, Ranjha NM, Raza MR et al. Enteric-coated Ca-alginate hydrogel beads: a promising tool for colon targeted drug delivery system. Polym. Bull. 2021; 78: 5103-5117. [CrossRef]
• [17] Piras CC, Slavik P, Smith DK. Self-Assembling Supramolecular Hybrid Hydrogel Beads. Angew Chem Int Edit. 2020; 59(2): 853-859. [CrossRef]
• [18] Nochos A, Douroumis D, Bouropoulos N. In vitro release of bovine serum albumin from alginate/HPMC hydrogel beads. Carbohydr. Polym. 2008; 74(3): 451-457. [CrossRef]
• [19] Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int. J. Pharm. 2006; 323(1-2): 34-42. [CrossRef]
• [20] Patel N, Lalwani D, Gollmer S, Injeti E, Sari Y, Nesamony J. Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation. Prog Biomater. 2016; 5(2): 117-133. [CrossRef]
• [21] Manjanna K.M SB, Pramod Kumar T.M. Diclofenac Sodium Microbeads for Oral Sustained Drug Delivery. International Journal of PharmTech Research. 2009; 1(2): 317-327.
• [22] Lozano-Vazquez G, Lobato-Calleros C, Escalona-Buendia H, Chavez G, Alvarez-Ramirez J, Vernon-Carter EJ. Effect of the weight ratio of alginate-modified tapioca starch on the physicochemical properties and release kinetics of chlorogenic acid containing beads. Food Hydrocolloid. 2015; 48: 301-311. [CrossRef]
• [23] Barreneche C, Fernandez AI, Cabeza LF, Cuypers R. Thermophysical characterization of sorption TCM. Enrgy Proced. 2014; 48: 273-279. [CrossRef]
• [24] Hariyadi DM, Islam N. Current Status of Alginate in Drug Delivery. Adv Pharmacol Pharm Sci. 2020; 2020: 1-16. [CrossRef]
• [25] Sivadas N, O'Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG, Hickey AJ, Cryan SA. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm. 2008; 358(1-2): 159-167. [CrossRef]
• [26] Ashrafi H, Azadi A. Chitosan-based hydrogel nanoparticle amazing behaviors during transmission electron microscopy. Int J Biol Macromol. 2016; 84: 31-34. [CrossRef]
• [27] Jafari-Aghdam N, Adibkia K, Payab S, Barzegar-Jalali M, Parvizpur A, Mohammadi G, et al. Methylprednisolone acetate-Eudragit((R)) RS100 electrospuns: Preparation and physicochemical characterization. Artif Cell Nanomed B. 2016; 44(2): 497-503. [CrossRef]
• [28] Liu CK, Wu YG, Zhao LY, Huang XZ. Preparation of acetylsalicylic acid-acylated chitosan as a novel polymeric drug for drug controlled release. Int J Biol Macromol. 2015; 78: 189-194. [CrossRef]
• [29] Ghezzi P. Role of glutathione in immunity and inflammation in the lung. Int J Gen Med. 2011; 4: 105-113. [CrossRef]
• [30] Hook VYH, Reisine TD. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: Role of BACE 1 in the constitutive secretory pathway. J Neurosci Res. 2003; 74(3): 393-405. [CrossRef]
• [31] Jain SK. L-Cysteine supplementation as an adjuvant therapy for type-2 diabetes. Can J Physiol Pharm. 2012; 90(8): 1061-1064. [CrossRef]
• [32] Ji HJ, Liu YK, Zhao XL, Zhang M. N-acetyl-L-cysteine enhances the osteogenic differentiation and inhibits the adipogenic differentiation through up regulation of Wnt 5a and down regulation of PPARG in bone marrow stromal cells. Biomed. Pharmacother. 2011; 65(5): 369-374. [CrossRef]
• [33] Walters MT, Rubin CE, Keightley SJ, Ward CD, Cawley MI. A double-blind, cross-over, study of oral N-acetylcysteine in Sjogren's syndrome. Scand J Rheumatol Suppl. 1986; 61: 253-258.
• [34] Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, et al. Combined Use of Nitroglycerin and N-Acetylcysteine in the Management of Unstable Angina-Pectoris. Circulation. 1988; 77(4): 787-794. [CrossRef]
• [35] Schmitz T, Grabovac E, Palmberger TE, Hoffer MH, Bemkop-Schnurch A. Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate. Int J Pharm. 2008; 347(1-2): 79-85. [CrossRef]
• [36] Branigan E, Pliotas C, Hagelueken G, Naismith JH. Quantification of free cysteines in membrane and soluble proteins using a fluorescent dye and thermal unfolding. Nat Protoc. 2013; 8(11): 2090-2097. [CrossRef]
• [37] Iswandana R, Putri KSS, Wulandari FR, Najuda G, Sari SP, Djajadisastra J. Preparation of Calcium Alginate-Tetrandrine Beads Using Ionic Gelation Method as Colon-Targeted Dosage Form. J App Pharm Sci. 2018; 8(05): 68-74. [CrossRef]
• [38] Rasmussen MR, Snabe T, Pedersen LH. Numerical modelling of insulin and amyloglucosidase release from swelling Ca-alginate beads. J Control Release. 2003; 91(3): 395-405. [CrossRef]
• [39] Yin ZC, Wang YL, Wang K. A pH-responsive composite hydrogel beads based on agar and alginate for oral drug delivery. J Drug Deliv Sci Tec. 2018; 43: 12-18. [CrossRef]
• [40] Smrdel P, Bogataj M, Podlogar F, Planinsek O, Zajc N, Mazaj M, et al. Characterization of calcium alginate beads containing structurally similar drugs. Drug Dev Ind Pharm. 2006; 32(5): 623-633. [CrossRef]